Literature DB >> 31616078

Ixekizumab superior to adalimumab for PsA.

Joanna Collison1.   

Abstract

Entities:  

Year:  2019        PMID： 31616078     DOI： 10.1038/s41584-019-0326-3

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

Review 1.  Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.

Authors:  Kevin L Winthrop; Michael E Weinblatt; Joan Bathon; Gerd R Burmester; Philip J Mease; Leslie Crofford; Vivian Bykerk; Maxime Dougados; James Todd Rosenbaum; Xavier Mariette; Joachim Sieper; Fritz Melchers; Bruce N Cronstein; Ferry C Breedveld; Joachim Kalden; Josef S Smolen; Daniel Furst
Journal:  Ann Rheum Dis       Date:  2019-10-29       Impact factor: 19.103
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.